Adagio Medical Holdings (ADGM) Return on Capital Employed (2025 - 2026)
Adagio Medical Holdings (ADGM) reported Return on Capital Employed of 59.94% for Q1 2026, up 1025.0% year-over-year from 5.33% in Q1 2025, and up 19.81% on a QoQ basis from 74.75% in Q4 2025.
Adagio Medical Holdings (ADGM) has 2 years of Return on Capital Employed data on file, last reported at 59.94% in Q1 2026.
- Quarterly Return on Capital Employed rose 1025.0% year-over-year to 59.94% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 59.94% (up 1025.0% YoY) and the FY2025 annual result came in at 58.19%, up 25620.0% from the prior year.
- Return on Capital Employed grew to 59.94% in Q1 2026 per ADGM's latest filing, from 74.75% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 59.94% in Q1 2026 and bottomed at 92.72% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Adagio Medical Holdings | 16.86 Mn | 3.95 Mn | - | -59.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.94% |
| Dec 31, 2025 | -74.75% |
| Sep 30, 2025 | -92.72% |
| Jun 30, 2025 | -68.79% |
| Mar 31, 2025 | -70.19% |